반응식
[F:1][C:2]1[CH:7]=[C:6]([I:8])[CH:5]=[CH:4][C:3]=1[O:9][C:10]1[CH:27]=[CH:26][C:13]2[CH2:14][CH2:15][N:16](C(OC(C)(C)C)=O)[CH2:17][CH2:18][C:12]=2[CH:11]=1.C(OC1C=CC2CCNCCC=2C=1)C1C=CC=CC=1>>[F:1][C:2]1[CH:7]=[C:6]([I:8])[CH:5]=[CH:4][C:3]=1[O:9][C:10]1[CH:27]=[CH:26][C:13]2[CH2:14][CH2:15][NH:16][CH2:17][CH2:18][C:12]=2[CH:11]=1참가 물질
3
실험 절차
The title compound was prepared from 1,1-dimethylethyl 7-[(2-fluoro-4-iodophenyl)oxy]-1,2,4,5-tetrahydro-3H-3-benzazepine-3-carboxylate (E274, Step 3) using an analogous method to that described for Description 2 (D2). MS (ES+) m/e 384 [M+H]+.
출처 및 근거
- ORD 기록
- ord-31300d95639945798109f957656f0d30
- 출처 데이터셋
- uspto-grants-2010_04
- 특허 번호
- US07704994B2
연결된 노트
불러오는 중…